decisionhealth Newsletters, Part B News - 2024 Issue 8 (August)
Loper Bright ruling brings new challenges to health care rules: Experts
Subscribe or sign in to view the full article.
Article Overview
This article examines the Supreme Court’s Loper Bright decision and its potential impact on federal health care rules, agency interpretations, and future legal challenges. It is aimed at health care providers, compliance leaders, attorneys, and policy professionals who follow Medicare, FDA, HHS, and related regulatory developments. The discussion focuses on broad litigation risk areas, regulatory authority, and how the post-Chevron legal environment may influence agencies and lawmakers.
Why This Topic Matters
The piece explains why a major Supreme Court change in administrative law could reshape how health care regulations are written, challenged, and defended. That matters for organizations that rely on federal rules for payment, coverage, compliance, and operational planning.
Article Sections
-
Supreme Court ruling and the end of Chevron deference
Introduces the Court decision and the broader shift in how federal agency interpretations may be reviewed. It frames the legal context for later discussion of health care regulation.
-
Potentially vulnerable health care and agency rules
Reviews categories of federal health care and adjacent regulations that experts think may face more challenges after the ruling. The section highlights several broad areas of agency activity without drilling into detailed outcomes.
-
Reasons some Medicare and physician payment rules may be less exposed
Explains why certain long-standing health care payment and coverage frameworks may remain more resilient than others. It focuses on the role of statutory language, agency delegation, and existing administrative structures.
-
Litigation timing, legislative drafting, and future regulatory caution
Discusses how the decision may affect the volume and timing of lawsuits, as well as how agencies and lawmakers may respond. It covers broader implications for drafting rules and statutes going forward.
What You Will Learn
- How the Supreme Court decision changes the general approach to reviewing federal agency rules
- Which broad categories of health care regulation may be more likely to face legal challenges
- Why some Medicare-related rules may be less vulnerable than other agency actions
- How future litigation and legislative drafting may be affected in the post-Chevron environment
Who Should Read This
- Health care providers
- Health care compliance professionals
- Health care attorneys
- Policy analysts
- Regulatory affairs professionals
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com